Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells

Journal of Experimental Medicine

Volumn 201, Issue 11, 2005, Pages 1837-1852

  Feldhahn, Niklas ^a   Klein, Florian ^a   Mooster, Jana L ^a   Hadweh, Paul ^a   Sprangers, Mieke ^a   Wartenberg, Maria ^b   Bekhite, Mohamed M ^b   Hofmann, Wolf Karsten ^c   Herzog, Sebastian ^d   Jumaa, Hassan ^d   Rowley, Janet D ^e   Müschen, Markus ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BCR ABL PROTEIN; BRUTON TYROSINE KINASE; LINK PROTEIN; PHOSPHOLIPASE C GAMMA; PROTEIN BCL X; PROTEIN KINASE SYK; STAT5 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL SURVIVAL; CHILD; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME SUBUNIT; FEMALE; GENE EXPRESSION; GENETIC LINKAGE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RNA SPLICING; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; UPREGULATION;

ADOLESCENT; ADULT; AGED; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR MIMICRY; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL;

EID: 22344440682     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20042101     Document Type: Article

References (31)

1. Look, A.T. 1997. Oncogenic transcription factors in the human acute leukemias. Science. 278:1059-1064.
2. Huettner, C.S., P. Zhang, R.A. Van Etten, and D.G. Tenen. 2000. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Genet. 24:57-60.
3. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature. 381:751-758.
4. Kato, I., T. Takai, and A. Kudo. 2002. The pre-B cell receptor signaling for apoptosis is negatively regulated by Fc gamma RIIB. J. Immunol. 168:534-629.
5. Küppers, R., U. Klein, M.L. Hansmann, and K. Rajewsky. 1999. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341:1520-1529.
6. Kanzler, H., R. Küppers, and M.L. Hansmann, and K. Rajewsky. 1996. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184:1495-1505.
7. Dykstra, M.L., R. Longnecker, and S.K. Pierce. 2001. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity. 14:57-67.
8. Klein, F., N. Feldhahn, L. Harder, H. Wang, M. Wartenberg, W.K. Hofmann, P. Wernet, R. Siebert, and M. Müschen. 2004. The BCR-ABL1 Kinase Bypasses Selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells. J. Exp. Med. 199: 673-685.
9. 2+ following B-cell receptor activation. EMBO J. 17:1973-1985.
10. Satterthwaite, A.B., and O.N. Witte. 2000. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175:120-127.
11. Middendorp, S., G.M. Dingjan, A. Maas, K. Dahlenborg, and R.W. Hendriks. 2003. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity. J. Immunol. 171:5988-5996.
12. Kersseboom, R., S. Middendorp, G.M. Dingjan, K. Dahlenborg, M. Reth, H. Jumaa, and R.W. Hendriks. 2003. Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in pre-B cells. J. Exp. Med. 198:91-98.
13. Middendorp, S., A.J.E. Zijstra, R. Kersseboom, G.M. Dingjan, H. Jumaa, and R. Hendriks. 2005. Tumor suppressor function of Bruton's tyrosine kinase is independent of its catalytic activity. Blood. 105:259-265.
14. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 350:423-426.
15. Druker, B.J., C.L. Sawyers, H. Kantarjian, D.J. Resta, S.F. Reese, J.M. Ford, R. Capdeville, and M. Talpaz. 2001. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344:1038-1042.
16. Klucher, K.M., D.V. Lopez, and G.Q. Daley. 1998. Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression. Blood. 91:3927-3934.
17. Wahl, M.I., A.C. Fluckiger, R.M. Kato, H. Park, O.N. Witte, and D.J. Rawlings. 1997. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc. Natl. Acad. Sci. USA. 94:11526-11533.
18. Goodman, P.A., C.M. Wood, A.O. Vassilev, C. Mao, and F.M. Uckun. 2003. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia. Leuk. Lymphoma. 44:1008-1011.
19. Perrotti, D., and B. Calabretta. 2002. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene. 21:8577-8583.
20. + hematopoietic progenitor cells. Leukemia. 18:727-733.
21. Nieborowska-Skorska, M. M.A. Wasik, A. Slupianek, P. Salomoni, T. Kitamura, B. Calabretta, and T. Skorski. 1999. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J. Exp. Med. 189:1229-1242.
22. Sillaber, C., F. Gesbert, D.A. Frank, and M. Sattler, and J.D. Griffin 2000. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood. 95:2118-2125.
23. Mahajan, S., A. Vassilev, N. Sun, Z. Ozer, C. Mao, and F.M. Uckun. 2001. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. J. Biol. Chem. 276:31216-31228.
24. Gesbert, F., and J.D. Griffin. 2000. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Blood. 96:2269-2276.
25. Hu, Y., Y. Liu, S. Pelletier, E. Buchdunger, M. Warmuth, D. Fabbro, M. Hallek, R.A. Van Etten, and S. Li. 2004. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat. Genet. 36:453-461.
26. Backesjo, C.M., L. Vargas, G. Superti-Furga, and C.I. Smith. 2002. Phosphorylation of Bruton's tyrosine kinase by c-Abl. Biochem. Biophys. Res. Commun. 299:505-510.
27. Laederach, A., K.W. Cradic, K.N. Brazin, J. Zamoon, B.D. Fulton, X.Y. Huang, and A.H. Andreotti. 2002. Competing modes of self-association in the regulatory domains of Bruton's tyrosine kinase: intramolecular contact versus asymmetric homodimerization. Protein Sci. 11:36-45.
28. Ohya, K., S. Kajigaya, A. Kitanaka, K. Yoshida, A. Miyazato, Y. Yamashita, T. Yamanaka, U. Ikeda, K. Shimada, K. Ozawa, and H. Mano. 1999. Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase. Proc. Natl. Acad. Sci. USA. 96:11976-11981.
29. Klein, F., N. Feldhahn, S. Lee, H. Wang, F. Ciuffi, M. von Elstermann, M.L. Toribio, H. Sauer, M. Wartenberg, V.S. Barath, et al. 2003. T lymphoid differentiation in human bone marrow. Proc. Natl. Acad. Sci. USA. 100:6747-6752.
30. Pear, W.S., J.P. Miller, L. Xu, J.C. Pui, B. Soffer, R.C. Quackenbush, A.M. Pendergast, R. Bronson, J.C. Aster, and M.L. Scott, and D. Baltimore. 1998. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 92:3780-3792.
31. Feldhahn, N., I. Schwering, S. Lee, M. Wartenberg, F. Klein, H. Wang, G. Zhou, S.M. Wang, J.D. Rowley, J. Hescheler, et al. 2002. Silencing of B cell receptor signals in human naive B cells. J. Exp. Med. 196:1291-1305.